Ann Intern Med. 2021 Feb 9:M20-8101. doi: 10.7326/M20-8101. Online ahead of print.
Clinicians must have access to the best available evidence to inform point-of-care decisions about the use of remdesivir in patients with COVID-19. This article provides updated advice from the American College of Physicians for clinicians based on an updated rapid review.
PMID:33560862 | PMC:PMC7983309 | DOI:10.7326/M20-8101